Eagle Pharmaceuticals Statistics
Total Valuation
EGRX has a market cap or net worth of $76.23 million. The enterprise value is $131.07 million.
| Market Cap | 76.23M |
| Enterprise Value | 131.07M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EGRX has 12.99 million shares outstanding.
| Shares Outstanding | 12.99M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 12.02% |
| Owned by Institutions (%) | 86.66% |
| Float | 8.39M |
Valuation Ratios
The trailing PE ratio is 6.45 and the forward PE ratio is 1.47. EGRX's PEG ratio is 0.91.
| PE Ratio | 6.45 |
| Forward PE | 1.47 |
| PS Ratio | 0.30 |
| Forward PS | 0.31 |
| PB Ratio | 0.30 |
| P/FCF Ratio | n/a |
| PEG Ratio | 0.91 |
Enterprise Valuation
| EV / Earnings | 10.97 |
| EV / Sales | 0.51 |
| EV / EBITDA | 2.29 |
| EV / EBIT | 3.72 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.28.
| Current Ratio | 2.16 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.23 |
| Debt / FCF | n/a |
| Interest Coverage | 5.79 |
Financial Efficiency
Return on equity (ROE) is 5.00% and return on invested capital (ROIC) is 5.21%.
| Return on Equity (ROE) | 5.00% |
| Return on Assets (ROA) | 3.00% |
| Return on Capital (ROIC) | 5.21% |
| Revenue Per Employee | $1.92M |
| Profits Per Employee | $89,164 |
| Employee Count | 134 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, EGRX has paid $17.22 million in taxes.
| Income Tax | 17.22M |
| Effective Tax Rate | 59.04% |
Stock Price Statistics
The stock price has decreased by -70.31% in the last 52 weeks. The beta is 0.51, so EGRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -70.31% |
| 50-Day Moving Average | 4.63 |
| 200-Day Moving Average | 6.49 |
| Relative Strength Index (RSI) | 65.25 |
| Average Volume (20 Days) | 241,435 |
Short Selling Information
The latest short interest is 925,908, so 7.13% of the outstanding shares have been sold short.
| Short Interest | 925,908 |
| Short Previous Month | 994,352 |
| Short % of Shares Out | 7.13% |
| Short % of Float | 11.03% |
| Short Ratio (days to cover) | 3.98 |
Income Statement
In the last 12 months, EGRX had revenue of $257.55 million and earned $11.95 million in profits. Earnings per share was $0.91.
| Revenue | 257.55M |
| Gross Profit | 179.88M |
| Operating Income | 41.01M |
| Pretax Income | 29.17M |
| Net Income | 11.95M |
| EBITDA | 57.18M |
| EBIT | 35.26M |
| Earnings Per Share (EPS) | $0.91 |
Balance Sheet
The company has $15.35 million in cash and $70.19 million in debt, giving a net cash position of -$54.84 million or -$4.22 per share.
| Cash & Cash Equivalents | 15.35M |
| Total Debt | 70.19M |
| Net Cash | -54.84M |
| Net Cash Per Share | -$4.22 |
| Equity (Book Value) | 252.04M |
| Book Value Per Share | 19.41 |
| Working Capital | 100.62M |
Cash Flow
In the last 12 months, operating cash flow was -$9.32 million and capital expenditures -$74,000, giving a free cash flow of -$9.39 million.
| Operating Cash Flow | -9.32M |
| Capital Expenditures | -74,000 |
| Free Cash Flow | -9.39M |
| FCF Per Share | -$0.72 |
Margins
Gross margin is 69.84%, with operating and profit margins of 15.92% and 4.64%.
| Gross Margin | 69.84% |
| Operating Margin | 15.92% |
| Pretax Margin | 11.33% |
| Profit Margin | 4.64% |
| EBITDA Margin | 22.20% |
| EBIT Margin | 13.69% |
| FCF Margin | -3.65% |
Dividends & Yields
EGRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.48% |
| Shareholder Yield | -2.48% |
| Earnings Yield | 15.67% |
| FCF Yield | -12.32% |
Analyst Forecast
The average price target for EGRX is $17.00, which is 189.61% higher than the current price. The consensus rating is "Sell".
| Price Target | $17.00 |
| Price Target Difference | 189.61% |
| Analyst Consensus | Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EGRX has an Altman Z-Score of 1.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.94 |
| Piotroski F-Score | 3 |